Mangoceuticals, Common Stock Stock Today
| MGRX Stock | 4.75 0.29 6.50% |
PerformanceGood
| Odds Of DistressLow
|
Mangoceuticals, Common is trading at 4.75 as of the 24th of March 2025; that is 6.50 percent up since the beginning of the trading day. The stock's open price was 4.46. Mangoceuticals, Common has less than a 19 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 21st of March 2023 | Category Healthcare | Classification Health Care |
Mangoceuticals, Common is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 4.97 M outstanding shares of which 71.47 K shares are now shorted by private and institutional investors with about 0.41 trading days to cover. More on Mangoceuticals, Common Stock
Moving together with Mangoceuticals, Stock
Moving against Mangoceuticals, Stock
Mangoceuticals, Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO CoFounder | Jacob Cohen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Healthcare (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Healthcare, Health Care, Health Care Equipment & Supplies, Medical Care Facilities, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mangoceuticals, Common can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Mangoceuticals, Common's financial leverage. It provides some insight into what part of Mangoceuticals, Common's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mangoceuticals, Common Stock (MGRX) is traded on NASDAQ Exchange in USA. It is located in 15110 North Dallas Parkway, Dallas, TX, United States, 75248 and employs 3 people. Mangoceuticals, Common is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.16 M. Mangoceuticals, Common conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 4.97 M outstanding shares of which 71.47 K shares are now shorted by private and institutional investors with about 0.41 trading days to cover.
Mangoceuticals, Common generates negative cash flow from operations
Check Mangoceuticals, Common Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Mangoceuticals, Common Stock is USD22.16 Million. Mangoceuticals, Common Stock holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Mangoceuticals, Ownership Details
Mangoceuticals, Common Historical Income Statement
Mangoceuticals, Stock Against Markets
Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.